表紙
市場調査レポート

生物学的安全性検査の世界市場 2019年:幹細胞・血液・遺伝子治療

Biological Safety Testing Market by Application (Stem Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), Test (Bioburden, Endotoxin, Cell Line Authentication, Residual Contamination, Adventitious Agents): Global Forecast - 2019

発行 MarketsandMarkets 商品コード 328907
出版日 ページ情報 英文 171 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
生物学的安全性検査の世界市場 2019年:幹細胞・血液・遺伝子治療 Biological Safety Testing Market by Application (Stem Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), Test (Bioburden, Endotoxin, Cell Line Authentication, Residual Contamination, Adventitious Agents): Global Forecast - 2019
出版日: 2015年04月21日 ページ情報: 英文 171 Pages
概要

世界の生物学的安全性検査市場は2014年から2019年間に12.23%のCAGRで成長し、2019年には17億5869万米ドルに達する見込みです。

当レポートでは、世界の生物学的安全性検査市場について調査分析し、製品、試験種類、用途および地域別の分析・予測を提供しており、競合情勢の分析、主要企業のプロファイルなどをまとめ、お届けします。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界の生物学的安全性検査市場における利益の上がる機会
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
  • 市場区分
    • アプリケーション別
    • 製品別
    • 検査別
  • 市場ダイナミクス
    • 促進因子
    • 阻害因子
    • 機会
    • 課題

第6章 産業動向

  • イントロダクション
  • ポーターのファイブフォース分析
  • 戦略的ベンチマーキング
  • サプライチェーン分析

第7章 生物学的安全性検査市場:用途別

  • イントロダクション
  • ワクチン・治療
  • 血液・血液製剤
  • 細胞・遺伝子治療製品
  • 細胞・細胞製品
  • 幹細胞製品

第8章 生物学的安全性検査市場:製品別

  • イントロダクション
  • キット & 試薬
  • サービス
  • 器具

第9章 生物学的安全性検査市場:検査別

  • イントロダクション
  • エンドトキシン検査
  • 不妊検査
  • 細胞株認証・特性化試験
  • バイオバーデン試験
  • 残留宿主汚染物質検出試験
  • 偶発性化学物質検出試験
  • その他の試験

第10章 地域分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他

第11章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合状況 & 動向

第12章 企業プロファイル

  • イントロダクション
  • Charles River Laboratories International, Inc.
  • Lonza Group
  • Sigma-Aldrich Corporation
  • SGS S.A.
  • Wuxi Pharmatech (Cayman) Inc.
  • Avance Biosciences Inc.
  • Bsl Bioservice
  • Cytovance Biologics, Inc.
  • Merck & Co., Inc.
  • Toxikon Corporation

第13章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 3334

The biologics safety testing market is growing at a favorable rate. The major drivers for the market include growth of the pharmaceutical and biological industries and an increasing number of new drug launches. Over the years, the number of drug approvals in North American countries has increased. Between 2001 and 2010, the FDA approved 225 drug applications and Health Canada approved 99. In addition, according to WIPO, Europe accounted for 3,822 of the pharmaceutical and 1,998 of the biotechnology patents granted in 2012. Furthermore, according to OECD estimates, in 2011, the total number of biotechnology companies in the U.S. was 7,970. This will spur the growth of biologics safety testing market.

The global pharmaceutical industry is expected to grow at a CAGR between 5% and 8%. According to the IMS Institute of Healthcare Informatics, the global biologics market has increased from $46 billion in 2002 to $169 billion in 2012. Biologics accounted for 11% of the total sales of drugs in 2002, which increased to 18% in 2012. It is estimated that this figure will rise to 20% by 2017, with a total market value of $221 billion. According to Ernst & Young's Global Biotechnology Report 2013, companies in biotech centers in the U.S., Europe, Canada, and Australia achieved revenues of about $90 billion in 2012. This was an 8% increase over their revenues in 2011. According to OECD estimates, in 2011, the total number of biotechnology companies in the U.S. was 7,970, followed by Spain (3,025 biotechnology companies), and France (1,481 biotechnology companies). Owing to the rise in the number of biotechnology companies, biopharmaceutical production has increased globally. Biologics safety testing is carried out at all levels of pharmaceutical and biopharmaceutical manufacturing process to minimize the risk of product contamination. Growth in pharmaceutical and biotechnology industries will drive the growth of the biologics safety testing market.

This report segments the global biologic safety testing market based on product, type of test, application, and geography. The product segments included in the report are instruments, kits & reagents, and services. Based on test, this market is categorized into adventitious agents detection test, bioburden tests, cell line authentication and characterization tests, endotoxin tests, residual host contaminant detection tests, sterility testing, and other tests (efficacy tests, toxicity tests, stability tests). The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissues & tissue products, and vaccines and therapeutics.

The geographic segments included in this report are Asia, Europe, North America and the Rest of the World (RoW). Asia is further divided into China, India, Japan, and the Rest of Asia. North America includes Canada and the U.S.

A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global biologics safety testing market and its subsegments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their biologics safety testing market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and the growth rates of each subsegment and identifies segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the biologic safety testing market. The competitive landscape covers growth strategies adopted by industry players over the last three years, and includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development/Innovation: Product portfolios of top players in the biologic safety testing market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the biologic safety testing market
  • Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of leading players in the biologic safety testing market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various biologics safety testing products across geographies
  • Market Diversification: Exhaustive information about new products and services, recent developments, and investments in the biologics safety testing market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Scope
    • 1.3.1. Markets Covered
    • 1.3.2. Years Considered for the Study
  • 1.4. Currency
  • 1.5. Stakeholders

2. Research Methodology

  • 2.1. Market Size Estimation
  • 2.2. Market Breakdown and Data Triangulation
  • 2.3. Market Share Estimation
    • 2.3.1. Key Data From Secondary Sources
    • 2.3.2. Key Data From Primary Sources
    • 2.3.3. Assumptions for the Study

3. Executive Summary

4. Premium Insights

  • 4.1. Lucrative Opportunities in the Global Biologics Safety Testing Market
  • 4.2. Life Cycle Analysis, By Region

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Segmentation
    • 5.2.1. By Application
    • 5.2.2. By Product
    • 5.2.3. By Test
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
      • 5.3.1.1. Rapid Growth in Pharmaceutical and Biotechnology Industries
      • 5.3.1.2. Increasing Number of New Drug Launches
      • 5.3.1.3. Strong Trend of R&D Investments in Life Sciences
      • 5.3.1.4. Increasing Government Support for Pharmaceutical and Biotechnology Industries
      • 5.3.1.5. High Incidence and Large Economic Burden of Chronic Diseases
    • 5.3.2. Restraints
      • 5.3.2.1. High Degree of Consolidation Acts as an Entry Barrier for New Entrants
    • 5.3.3. Opportunities
      • 5.3.3.1. Increasing Pharmaceutical Outsourcing
      • 5.3.3.2. Developing Countries
    • 5.3.4. Challenges
      • 5.3.4.1. Stringent Regulatory Frameworks and Time-Consuming Approval Processes

6. Industry Insights

  • 6.1. Introduction
  • 6.2. Porter's Five Forces Analysis
    • 6.2.1. Threat From New Entrants
    • 6.2.2. Threat From Substitutes
    • 6.2.3. Bargaining Power of Buyers
    • 6.2.4. Bargaining Power of Suppliers
    • 6.2.5. Intensity of Rivalry
  • 6.3. Strategic Benchmarking
    • 6.3.1. Expansions and Acquisitions
  • 6.4. Supply Chain Analysis
    • 6.4.1. Key Influencers

7. Biologics Safety Testing Market, By Application

  • 7.1. Introduction
  • 7.2. Vaccines and Therapeutics
  • 7.3. Blood and Blood Products
  • 7.4. Cellular and Gene Therapy Products
  • 7.5. Tissue and Tissue Products
  • 7.6. Stem Cell Products

8. Biologics Safety Testing Market, By Product

  • 8.1. Introduction
  • 8.2. Kits & Reagents
  • 8.3. Services
  • 8.4. Instruments

9. Biologics Safety Testing Market, By Tests

  • 9.1. Introduction
  • 9.2. Endotoxin Tests
  • 9.3. Sterility Tests
  • 9.4. Cell Line Authentication and Characterization Tests
  • 9.5. Bioburden Tests
  • 9.6. Residual Host Contaminant Detection Tests
  • 9.7. Adventitious Agent Detection Tests
  • 9.8. Other Tests

10. Geographic Analysis

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
  • 10.4. Asia
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Rest of Asia (RoA)
  • 10.5. Rest of the World (RoW)

11. Competitive Landscape

  • 11.1. Overview
  • 11.2. Market Share Analysis
  • 11.3. Competitive Situation and Trends
    • 11.3.1. Expansions
    • 11.3.2. Acquisitions
    • 11.3.3. Agreements, Collaborations, and Partnerships
    • 11.3.4. New Product and Service Launches
    • 11.3.5. Other Developments

12. Company Profiles

  • 12.1. Introduction
  • 12.2. Charles River Laboratories International, Inc.
    • 12.2.1. Business Overview
    • 12.2.2. Products & Services
    • 12.2.3. Recent Developments
    • 12.2.4. MNM View
      • 12.2.4.1. Financial Analysis
      • 12.2.4.2. Strategic Analysis
  • 12.3. Lonza Group
    • 12.3.1. Business Overview
    • 12.3.2. Products & Services
    • 12.3.3. Recent Developments
    • 12.3.4. MNM View
      • 12.3.4.1. Financial Analysis
      • 12.3.4.2. Strategic Analysis
  • 12.4. Sigma-Aldrich Corporation
    • 12.4.1. Business Overview
    • 12.4.2. Products & Services
    • 12.4.3. Recent Developments
    • 12.4.4. MNM View
      • 12.4.4.1. Financial Analysis
      • 12.4.4.2. Strategic Analysis
  • 12.5. SGS S.A.
    • 12.5.1. Business Overview
    • 12.5.2. Services Portfolio
    • 12.5.3. Recent Developments
    • 12.5.4. MNM View
  • 12.6. Wuxi Pharmatech (Cayman) Inc.
    • 12.6.1. Business Overview
    • 12.6.2. Services Portfolio
    • 12.6.3. Recent Developments
    • 12.6.4. MNM View
      • 12.6.4.1. Financial Analysis
      • 12.6.4.2. Strategic Analysis
  • 12.7. Avance Biosciences Inc.
    • 12.7.1. Business Overview
    • 12.7.2. Services Portfolio
  • 12.8. Bsl Bioservice
    • 12.8.1. Business Overview
    • 12.8.2. Services Portfolio
  • 12.9. Cytovance Biologics, Inc.
    • 12.9.1. Business Overview
    • 12.9.2. Services Portfolio
  • 12.10. Merck & Co., Inc.
    • 12.10.1. Business Overview
    • 12.10.2. Products & Services
    • 12.10.3. Recent Developments
    • 12.10.4. Key Strategy
  • 12.11. Toxikon Corporation
    • 12.11.1. Business Overview
    • 12.11.2. Products & Services

13. Appendix

  • 13.1. Insights of Industry Experts
  • 13.2. Discussion Guide
  • 13.3. Introducing RT: Real-Time Market Intelligence
  • 13.4. Available Customizations
  • 13.5. Related Reports

List of Tables

  • Table 1: Biologics Safety Testing Market Summary
  • Table 2: Rapid Growth in the Pharmaceutical and Biotechnology Industries is Propelling the Growth of Biologics Safety Testing Market
  • Table 3: High Degree of Consolidation Acts as an Entry Barrier for New Entrants
  • Table 4: Increasing Pharmaceutical Outsourcing Are Paving New Growth Avenues for Players in the Biologics Safety Testing Market
  • Table 5: Stringent Regulatory Frameworks Are Major Challenges for Market Players
  • Table 6: Market Developments Between 2011 and 2014
  • Table 7: Biological Safety Testing Market Size, By Application, 2012-2019 ($Million)
  • Table 8: Biologics Safety Testing Market Size for Vaccines and Therapeutics, By Region, 2012-2019 ($Million)
  • Table 9: Biological Safety Testing Market Size for Blood and Blood Products, By Region, 2012-2019 ($Million)
  • Table 10: Biological Safety Testing Market Size for Cellular and Gene Therapy Products, By Region, 2012-2019 ($Million)
  • Table 11: Biologics Safety Testing Market Size for Tissue and Tissue Products, By Region, 2012-2019 ($Million)
  • Table 12: Market Size for Stem Cell Products, By Region, 2012-2019 ($Million)
  • Table 13: Biological Safety Testing Market Size, By Product, 2012-2019 ($Million)
  • Table 14: Biologics Safety Testing Kits and Reagents Market Size, By Region, 2012-2019 ($Million)
  • Table 15: North America: Biological Safety Testing Kits and Reagents Market Size, By Country, 2012-2019 ($Million)
  • Table 16: Asia: Biologics Safety Testing Kits and Reagents Market Size, By Country, 2012-2019 ($Million)
  • Table 17: Biological Safety Testing Services Market Size, By Region, 2012-2019 ($Million)
  • Table 18: North America: Biologics Safety Testing Services Market Size, By Country, 2012-2019 ($Million)
  • Table 19: Asia: Biological Safety Testing Services Market Size, By Country, 2012-2019 ($Million)
  • Table 20: Biologics Safety Testing Instruments Market Size, By Region, 2012-2019 ($Million)
  • Table 21: North America: Biological Safety Testing Instruments Market Size, By Country, 2012-2019 ($Million)
  • Table 22: Asia: Biological Safety Testing Instruments Market Size, By Country, 2012-2019 ($Million)
  • Table 23: Biologics Safety Testing Market, By Test, 2012-2019 ($Million)
  • Table 24: Biological Safety Testing Market for Endotoxin Tests, By Region, 2012-2019 ($Million)
  • Table 25: North America: Market for Endotoxin Tests, By Region, 2012-2019 ($Million)
  • Table 26: Asia: Biological Safety Testing Market for Endotoxin Tests, By Region, 2012-2019 ($Million)
  • Table 27: Biologics Safety Testing Market for Sterility Tests, By Region, 2012-2019 ($Million)
  • Table 28: North America: Biologics Safety Tests Market for Sterility Tests, By Region, 2012-2019 ($Million)
  • Table 29: Asia: Biologics Safety Tests Market for Sterility Tests, By Region, 2012-2019 ($Million)
  • Table 30: Biological Safety Testing Market for Cell Line Authentication and Characterization Tests, By Region, 2012-2019 ($Million)
  • Table 31: North America: Biological Safety Testing Market for Cell Line Authentication and Characterization Tests, By Region, 2012-2019 ($Million)
  • Table 32: Asia: Biologics Safety Testing Market for Cell Line Authentication and Characterization Tests, By Region, 2012-2019 ($Million)
  • Table 33: Biological Safety Testing Market for Bioburden Tests, By Region, 2012-2019 ($Million)
  • Table 34: North America Biologics Safety Testing Market for Bioburden Tests, By Region, 2012-2019 ($Million)
  • Table 35: Asia: Biological Safety Testing Market for Bioburden Tests, By Region, 2012-2019 ($Million)
  • Table 36: Market for Residual Host Contaminant Detection Tests, By Region, 2012-2019 ($Million)
  • Table 37: North America: Biological Safety Testing Market for Residual Host Contaminant Detection Tests, By Region, 2012-2019 ($Million)
  • Table 38: Asia: Biologics Safety Testing Market for Residual Host Contaminant Detection Tests, By Region, 2012-2019 ($Million)
  • Table 39: Biological Safety Testing Market for Adventitious Agent Detection Tests, By Region, 2012-2019 ($Million)
  • Table 40: North America: Biologics Safety Testing Market for Adventitious Agent Detection Tests, By Region, 2012-2019 ($Million)
  • Table 41: Asia: Biological Safety Testing Market for Adventitious Agent Detection Tests, By Region, 2012-2019 ($Million)
  • Table 42: Biologics Safety Testing Market for Other Tests, By Region, 2012-2019 ($Million)
  • Table 43: North America: Biologics Safety Tests Market for Other Tests, By Region, 2012-2019 ($Million)
  • Table 44: Asia: Biological Safety Testing Market for Other Tests, By Region, 2012-2019 ($Million)
  • Table 45: Biologics Safety Testing Market Size, By Region, 2012-2019 ($Million)
  • Table 46: North America: Biological Safety Testing Market Size, By Region, 2012-2019 ($Million)
  • Table 47: North America: Biologics Safety Testing Market Size, By Product, 2012-2019 ($Million)
  • Table 48: North America: Market Size, By Application, 2012-2019 ($Million)
  • Table 49: North America: Market Size, By Test, 2012-2019 ($Million)
  • Table 50: U.S.: Biologics Safety Testing Market Size, By Product, 2012-2019 ($Million)
  • Table 51: U.S.: Market Size, By Application, 2012-2019 ($Million)
  • Table 52: Canada: Biologics Safety Testing Market Size, By Product, 2012-2019 ($Million)
  • Table 53: Canada: Market Size, By Application, 2012-2019 ($Million)
  • Table 54: Europe: Biological Safety Testing Market Size, By Product, 2012-2019 ($Million)
  • Table 55: Europe: Market Size, By Application, 2012-2019 ($Million)
  • Table 56: Europe: Market Size, By Test, 2012-2019 ($Million)
  • Table 57: Asia: Biologics Safety Testing Market Size, By Region, 2012-2019 ($Million)
  • Table 58: Asia: Biological Safety Testing Market Size, By Product, 2012-2019 ($Million)
  • Table 59: Asia: Market Size, By Application, 2012-2019 ($Million)
  • Table 60: Asia: Market Size, By Test, 2012-2019 ($Million)
  • Table 61: China: Market Size, By Product, 2012-2019 ($Million)
  • Table 62: China: Biological Safety Testing Market Size, By Application, 2012-2019 ($Million)
  • Table 63: Japan: Biologics Safety Testing Market Size, By Product, 2012-2019 ($Million)
  • Table 64: Japan: Biological Safety Testing Market Size, By Application, 2012-2019 ($Million)
  • Table 65: India: Market Size, By Product, 2012-2019 ($Million)
  • Table 66: India: Market Size, By Application, 2012-2019 ($Million)
  • Table 67: RoA: Biologics Safety Testing Market Size, By Product, 2012-2019 ($Million)
  • Table 68: RoA: Market Size, By Application, 2012-2019 ($Million)
  • Table 69: RoW: Market Size, By Product, 2012-2019 ($Million)
  • Table 70: RoW: Market Size, By Application, 2012-2019 ($Million)
  • Table 71: RoW: Biological Safety Testing Market Size, By Test, 2012-2019 ($Million)
  • Table 72: Market Share Analysis, By Key Player, 2014
  • Table 73: Expansions, 2012-2015
  • Table 74: Acquisitions, 2012-2015
  • Table 75: New Product and Service Launches, 2012-2015
  • Table 76: Other Developments, 2012-2015

List of Figures

  • Figure 1: Global Biologics Safety Testing Market
  • Figure 2: Research Methodology
  • Figure 3: Market Size Estimation Methodology: Bottom-Up Approach
  • Figure 4: Market Size Estimation Methodology: Top-Down Approach
  • Figure 5: Breakdown of Primary Interviews: By Company Type, Designation, and Region
  • Figure 6: Data Triangulation Methodology
  • Figure 7: Biologics Safety Testing Market Size, By Product, 2014 vs. 2019 ($Million)
  • Figure 8: Biological Safety Testing Market Size, By Application, 2014 vs. 2019 ($Million)
  • Figure 9: Market Size, By Test, 2014 vs. 2019 ($Million)
  • Figure 10: Biologics Testing Market Size, By Region, 2014 vs. 2019 ($Million)
  • Figure 11: Increase in Pharmaceutical and Biotechnology Industries Will Drive Market Growth
  • Figure 12: Kits and Reagents Segment Accounted for the Largest Market Share in 2014
  • Figure 13: Asian Market to Experience Fastest Growth in the Forecast Period (2014 to 2019)
  • Figure 14: Asia Poised for Lucrative Growth
  • Figure 15: Biologics Safety Testing Market Segmentation: By Application
  • Figure 16: Biological Safety Testing Market Segmentation: By Product
  • Figure 17: Market Segmentation: By Test
  • Figure 18: Growth in Pharmaceutical and Biotechnology Industries Will Drive the Biological Safety Testing Market
  • Figure 19: Increasing Number of New Drug Launches to Drive the Biologics Safety Testing Market
  • Figure 20: High Capital Investments to Restrict the Entry of New Players
  • Figure 21: Direct Distribution Strategy Preferred By Prominent Companies
  • Figure 22: Biologics Safety Testing Market, By Application
  • Figure 23: Biological Safety Testing Market Size, By Application, 2014 ($Million)
  • Figure 24: Vaccine and Therapeutics Will Be the Fastest-Growing Application Segment of the Biologics Safety Testing Market
  • Figure 25: North America Dominated the Blood and Blood Products Application Segment in 2104
  • Figure 26: Asia to Witness Highest Growth in the Cellular and Gene Therapy Products Application Segment
  • Figure 27: North America to Command Largest Share of the Tissue and Tissue Products Application Segment in the Forecast Period
  • Figure 28: Asia to Witness Highest Growth in the Stem Cell Products Application Segment
  • Figure 29: Market Segmentation, By Product
  • Figure 30: Biological Safety Testing Market Size, By Product, 2014 ($Million)
  • Figure 31: North America Dominated the Biologics Safety Testing Kits and Reagents Market in 2014
  • Figure 32: U.S. to Dominate the Biological Safety Testing Kits and Reagents Market in North America
  • Figure 33: China to Dominate the Biologics Safety Testing Kits and Reagents Market in Asia
  • Figure 34: Asia to Witness the Highest Growth in the Biological Safety Testing Services Market in the Forecast Period
  • Figure 35: U.S. to Dominate the Biologics Safety Testing Services Market in North America
  • Figure 36: China to Dominate the Biological Safety Testing Services Market in Asia
  • Figure 37: North America to Dominate the Biologics Safety Testing Instruments Market in the Forecast Period
  • Figure 38: U.S. to Dominate the Biological Safety Testing Instruments Market in North America
  • Figure 39: China to Dominate the Biologics Safety Testing Instruments Market in Asia
  • Figure 40: Biologics Safety Testing Market, By Test
  • Figure 41: Market Size, By Test, 2014-2019 ($Million)
  • Figure 42: North America to Account for the Largest Share of the Endotoxin Tests Segment
  • Figure 43: The U.S. to Account for the Largest Share in the Endotoxin Tests Segment in North America
  • Figure 44: China to Account for the Largest Share in the Endotoxin Tests Market in Asia
  • Figure 45: North America to Account for the Largest Share in the Sterility Tests Segment
  • Figure 46: The U.S. to Account for the Largest Share of the Sterility Tests Segment in North America
  • Figure 47: China to Account for the Largest Share in the Sterility Tests Segment in Asia
  • Figure 48: North America Will Account for the Largest Share in the Cell Line Authentication and Characterization Tests Segment
  • Figure 49: The U.S. to Account for the Largest Share of the Cell Line Authentication and Characterization Tests Segment in North America
  • Figure 50: China to Account for the Largest Share in the Cell Line Authentication and Characterization Tests Segment in Asia
  • Figure 51: North America to Account for the Largest Share in the Bioburden Tests Segment
  • Figure 52: The U.S. to Account for the Largest Share in the Bioburden Tests Segment in North America
  • Figure 53: China to Account for the Largest Share in the Bioburden Tests Segment in Asia
  • Figure 54: North America to Account for the Largest Share of the Residual Host Contaminant Detection Tests Segment
  • Figure 55: The U.S. to Account for the Largest Share in the Residual Host Contaminant Detection Tests Segment in North America
  • Figure 56: China to Account for the Largest Share in the Residual Host Contaminant Detection Tests Segment in Asia
  • Figure 57: North America to Account for the Largest Share in the Adventitious Agent Detection Tests Segment
  • Figure 58: The U.S. to Account for the Largest Share in the Adventitious Agent Detection Tests Segment in North America
  • Figure 59: China to Account for the Largest Share in the Adventitious Agent Detection Tests Segment in Asia
  • Figure 60: North America to Account for the Largest Share in the Other Tests Segment
  • Figure 61: The U.S. to Account for the Largest Share in the Other Tests Segment in North America
  • Figure 62: China to Account for the Largest Share in the Other Tests Segment in Asia
  • Figure 63: Biologics Safety Testing Market Segmentation, By Region
  • Figure 64: Biological Safety Testing Market Size, By Region (Market Size and Growth Rate), 2014-2019
  • Figure 65: Asian Market for Biologics Safety Testing Expected to Grow at the Highest Rate From 2014 to 2019
  • Figure 66: North America: Market Snapshot
  • Figure 67: North America: Market, By Region (Market Size and Growth Rate), 2014-2019
  • Figure 68: Kits and Reagents Held the Largest Share of the Biologics Safety Testing Market in North America in 2014
  • Figure 69: Vaccines and Therapeutics Formed the Largest Application Segment in North America
  • Figure 70: Endotoxin Tests Formed the Largest Test Segment in North America in 2014
  • Figure 71: Kits and Reagents Formed the Largest Product Segment in the U.S.
  • Figure 72: Vaccines and Therapeutics Application Segment Held the Largest Share in the U.S. Market
  • Figure 73: Kits and Reagents Held the Largest Share Among All Product Segments in Canada
  • Figure 74: Vaccines and Therapeutics Formed the Largest Application Segment in Canada
  • Figure 75: Kits and Reagents Held the Largest Share of the Biologics Safety Testing Products Market in Europe
  • Figure 76: Vaccines and Therapeutics Formed the Largest Application Segment in Europe in 2014
  • Figure 77: Endotoxin Tests Accounted for the Largest Share of Biologics Safety Testing Market
  • Figure 78: Asia: Market Snapshot
  • Figure 79: Asia: Biologics Safety Testing Market, By Region (Market Size and Growth Rate)
  • Figure 80: Kits and Reagents Product Segment Dominated Asian Biologics Safety Testing Market in 2014
  • Figure 81: Vaccines and Therapeutics Application Segment Accounted for Largest Share of Asian Biologics Safety Testing Market
  • Figure 82: Endotoxin Tests Accounted for the Largest Share of the Market in Asia
  • Figure 83: Kits and Reagents Were the Largest Product Segment in China in 2014
  • Figure 84: Vaccines and Therapeutics Held the Largest Share of the Chinese Market in 2014
  • Figure 85: Kits and Reagents Formed the Largest Product Segment in Japan
  • Figure 86: Vaccines and Therapeutics Application Segment Held the Largest Share of the Japanese Market
  • Figure 87: Kits and Reagents Formed the Largest and Fastest-Growing Product Segment in India
  • Figure 88: Vaccines and Therapeutics Form the Largest and the Fastest-Growing Application Segment in India
  • Figure 89: Kits and Reagents Commanded the Largest Share of the RoA Biologics Safety Testing Market in 2014
  • Figure 90: Vaccines and Therapeutics Application Segment Dominates RoA Market
  • Figure 91: Kits and Reagents Commanded the Largest Share of the RoW Biologics Safety Testing Market, By Product
  • Figure 92: Vaccines and Therapeutics Were the Largest Application Segment in 2014
  • Figure 93: Endotoxin Tests Segment Dominates RoW Market
  • Figure 94: Expansions and Acquisitions Are the Key Strategies Adopted By Players
  • Figure 95: Battle for Market Share: Expansions and Acquisitions Were the Key Strategies
  • Figure 96: Expansions, 2012-2015
  • Figure 97: Acquisitions, 2012-2015
  • Figure 98: Agreements, Collaborations, and Partnerships, 2012-2015
  • Figure 99: Agreements, Collaborations, and Partnerships, 2012-2015
  • Figure 100: New Product and Service Launches, 2012-2015
  • Figure 101: Other Developments, 2012-2015
  • Figure 102: Snapshot for the Financial Performances of the Leading Market Players
  • Figure 103: Charles River Laboratories International, Inc.: Company Snapshot
  • Figure 104: Lonza Group: Company Snapshot
  • Figure 105: Sigma-Aldrich Corporation: Company Snapshot
  • Figure 106: SGS SA: Company Snapshot
  • Figure 107: Wuxi Pharmatech (Cayman) Inc.: Company Snapshot
  • Figure 108: Merck & Co., Inc.: Company Snapshot
Back to Top